RCT outcomes predicted by RWE

  • FDA and Brigham and Women’s Hospital have expanded their previous RCT DUPLICATE demonstration project to predict the results of seven Phase IV trails that are currently ongoing
  • Part of the project will estimate the results of randomised controlled trials before they are finished with the use of RWE

Click here to see the source article 

Reference

Hale, C. (2019). Using real-world data, the FDA aims to predict randomized trial results before they’re done. [online] FierceBiotech. Available at: https://www.fiercebiotech.com/medtech/using-real-world-data-fda-aims-to-predict-randomized-trial-results-before-they-re-done [Accessed 21 May 2019].

 

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com

Posted in Blogs.